AAPL   396.25 (+3.28%)
MSFT   214.77 (+0.51%)
FB   248.04 (+1.21%)
GOOGL   1,564.49 (+1.66%)
AMZN   3,292.71 (+2.90%)
NVDA   423.93 (+1.14%)
CGC   18.07 (+3.73%)
BABA   258.55 (-0.94%)
MU   50.94 (+0.47%)
TSLA   1,698.58 (+9.97%)
T   29.92 (-0.70%)
DIS   119.90 (+0.47%)
NFLX   563.66 (+2.72%)
BAC   24.31 (+1.21%)
BA   181.75 (+1.85%)
AAPL   396.25 (+3.28%)
MSFT   214.77 (+0.51%)
FB   248.04 (+1.21%)
GOOGL   1,564.49 (+1.66%)
AMZN   3,292.71 (+2.90%)
NVDA   423.93 (+1.14%)
CGC   18.07 (+3.73%)
BABA   258.55 (-0.94%)
MU   50.94 (+0.47%)
TSLA   1,698.58 (+9.97%)
T   29.92 (-0.70%)
DIS   119.90 (+0.47%)
NFLX   563.66 (+2.72%)
BAC   24.31 (+1.21%)
BA   181.75 (+1.85%)
AAPL   396.25 (+3.28%)
MSFT   214.77 (+0.51%)
FB   248.04 (+1.21%)
GOOGL   1,564.49 (+1.66%)
AMZN   3,292.71 (+2.90%)
NVDA   423.93 (+1.14%)
CGC   18.07 (+3.73%)
BABA   258.55 (-0.94%)
MU   50.94 (+0.47%)
TSLA   1,698.58 (+9.97%)
T   29.92 (-0.70%)
DIS   119.90 (+0.47%)
NFLX   563.66 (+2.72%)
BAC   24.31 (+1.21%)
BA   181.75 (+1.85%)
AAPL   396.25 (+3.28%)
MSFT   214.77 (+0.51%)
FB   248.04 (+1.21%)
GOOGL   1,564.49 (+1.66%)
AMZN   3,292.71 (+2.90%)
NVDA   423.93 (+1.14%)
CGC   18.07 (+3.73%)
BABA   258.55 (-0.94%)
MU   50.94 (+0.47%)
TSLA   1,698.58 (+9.97%)
T   29.92 (-0.70%)
DIS   119.90 (+0.47%)
NFLX   563.66 (+2.72%)
BAC   24.31 (+1.21%)
BA   181.75 (+1.85%)
Log in

NASDAQ:KURAKura Oncology Earnings Date, Estimates & History

$18.24
+0.37 (+2.07 %)
(As of 07/13/2020 01:24 PM ET)
Add
Compare
Today's Range
$17.68
Now: $18.24
$18.24
50-Day Range
$15.45
MA: $17.05
$18.67
52-Week Range
$6.35
Now: $18.24
$21.15
Volume4,028 shs
Average Volume645,081 shs
Market Capitalization$828.83 million
P/E RatioN/A
Dividend YieldN/A
Beta2.29

Earnings

Kura Oncology (NASDAQ:KURA) Earnings Information

Kura Oncology last announced its earnings data on May 4th, 2020. The reported ($0.42) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.42). Kura Oncology has generated ($1.51) earnings per share over the last year. Kura Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 6th, 2020 based off prior year's report dates.

Kura Oncology Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Kura Oncology (NASDAQ:KURA) Earnings Estimates

2020 EPS Consensus Estimate: ($1.77)
2021 EPS Consensus Estimate: ($2.25)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($0.43)($0.33)($0.39)
Q2 20204($0.45)($0.40)($0.43)
Q3 20203($0.46)($0.37)($0.42)
Q4 20204($0.83)($0.35)($0.53)
Q1 20211($0.55)($0.55)($0.55)
Q2 20211($0.60)($0.60)($0.60)
Q3 20211($0.55)($0.55)($0.55)
Q4 20211($0.55)($0.55)($0.55)

Kura Oncology (NASDAQ KURA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/6/2020
(Estimated)
       
5/4/20203/31/2020($0.42)($0.42)($0.42)Transcript
2/25/2020Q4 2019($0.42)($0.39)($0.39)Transcript
11/5/2019Q3 2019($0.39)($0.36)($0.36)Transcript
8/1/2019Q2 2019($0.41)($0.38)($0.38)N/A
5/7/20193/31/2019($0.45)($0.37)($0.37)N/A
3/5/2019Q4 2018($0.43)($0.42)($0.42)Transcript
11/5/20189/30/2018($0.41)($0.40)($0.40)N/A
8/9/2018Q2 2018($0.45)($0.45)($0.45)N/A
5/8/2018Q1 2018($0.35)($0.46)($0.46)N/A
3/12/2018Q4 2017($0.36)($0.37)($0.37)Transcript
11/7/2017Q3 2017($0.37)($0.38)($0.38)N/A
8/7/2017Q2 2017($0.43)($0.40)($0.40)Listen
5/15/2017Q1 2017($0.44)($0.39)($0.39)N/A
3/14/2017Q4 2016($0.41)($0.38)($0.38)N/A
11/7/2016Q3($0.41)($0.37)($0.37)Listen
8/10/2016Q2($0.34)($0.36)($0.36)Listen
5/11/2016Q1($0.35)($0.36)($0.36)N/A
3/17/2016Q4($0.44)($0.42)($0.42)Listen
11/13/2015Q3 2015($0.42)($0.57)($0.57)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.